Compound Screening TRIZ Cases

Down-regulating MAST4 gene activity addresses limited pathogenesis understanding by reducing inflammation in seborrheic dermatitis.

Replacing radiolabeled substrates with a BODIPY-DNP dual-labeled molecule eliminates radioactive handling while maintaining measurement precision in HTS assays.

Engineered human heart tissue models replicate patient-specific cardiomyocyte function using induced pluripotent stem cell differentiation.

A neutralizing antibody binds epsilon toxin to block receptor interaction and protect oligodendrocytes.

An antibody binds myosin regulatory light chain polypeptides to block CD69 interaction and suppress inflammatory responses.

Method identifies ubiquitination-inducing compounds using eukaryotic cells with enhanced cullin-RING ligase activity.

Cyclic disulfide prodrugs release molecular cargo via selective enzymatic reduction, avoiding nonspecific thiol interference.

Covalent labeling of the nucleophilic active site cysteine in 3CLpro and PLpro enables fast screening for inhibitors with high cell permeability.

Extracting the PAN domain from HGF proteins creates stable inhibitors that resolve cost and instability trade-offs in MET pathway targeting.

Direct conversion of somatic cells into functional hepatocytes using specific transcription factors.

Phosphorylating FADD protein coordinates HSL and PPARα activity to resolve ineffective lipolysis regulation.

Delta133P53 beta and gamma isoforms serve as biomarkers to predict chemotherapy-induced cancer stem cell induction, enabling targeted therapeutic strategies.

Short oligopeptides reduce pro-inflammatory cytokine levels to mitigate multiple organ dysfunction syndrome after trauma hemorrhage.

Itolizumab strips CD6 from T cells to resolve the selectivity bottleneck in targeting pathogenic subsets.

Nuclear extract assays resolve single-molecule binding kinetics while maintaining biological relevance through microfluidic fluorescence detection.

An optical detection system replaces mechanical bead pick-up to reduce screening time and cost while maintaining identification accuracy.

A novel SARS-CoV-2 safe replicon system enables high-throughput drug screening independent of biosafety level 3 laboratories.

RNA biomarker detection identifies appendicitis without radiation exposure, resolving diagnostic accuracy versus safety trade-offs.

Humanized antibodies target the 24P4C12 protein to resolve detection accuracy and specificity limitations in early-stage cancer diagnosis.

Inhibiting prohibitin-AMPK complex formation accelerates activation, resolving time delays in therapeutic agent development.

GPRC6A taste receptors identify compounds to enhance pet food palatability, replacing subjective animal testing with precise biochemical binding assays.

A molecular probe functionalized element uses a peptide compound layer and dual linker system to covalently bind probes on biosensor surfaces.

Slit3 protein expression levels replace X-ray scanning to diagnose bone health without radiation exposure.

Engineered intestinal organoids use fluorescent hormone tags to track enteroendocrine cell differentiation and secretion.

A composition detects microglia using Olfr110 or Olfr111 odorant receptor expression levels.

Replacing glutamic acid with serine creates a phosphorylation-dependent protein motif that detects kinase and phosphatase activities.

Segmenting the enzyme into two subunits eliminates radioactive toxicity while maintaining reliable ligand detection accuracy.